Drug Trial Radar · NCT05322577
A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer.
Last checked: Nov 19, 2026Latest source record: Jul 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
72
Actual
Start
May 17, 2022
Primary completion
Nov 21, 2025
Study completion Nov 21, 2025
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Apr 12, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main objectives of this study are to evaluate the safety and tolerability of bemarituzumab in combination with other anti-cancer therapies, and to evaluate the efficacy of bemarituzumab in combination with S-1 and oxaliplatin (SOX) and nivolumab as assessed by objective response.
Conditions
- Gastric Cancer
- Gastroesophageal Junction Cancer
Interventions
BemarituzumabDrug
Intravenous (IV) infusion
CAPOXDrug
CAPOX administered as a combination of oxaliplatin as an IV infusion and capecitabine orally as tablets.
SOXDrug
SOX administered as a combination of oxaliplatin as an IV infusion and S-1 orally.
NivolumabDrug
IV infusion.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part 1: Number of Participants Who Experience a Dose-limiting Toxicity (DLT)Time frame: Day 1 up to Day 21
- Part 1: Number of Participants Who Experience a Treatment-emergent Adverse Event (TEAE)Time frame: Day 1 to end of treatment (up to approximately 1 year)
- Part 2: Objective Response (OR) as per Response Evaluation Criteria in Solid Tumors (RECIST v1.1)Time frame: Up to 30 Months
Locations
42 sites in 5 countries. Site status is shown where the registry gives one.
Northport Veterans Affairs Medical Center
Northport, New York
Fujita Health University Hospital
Toyoake-shi, Aichi-ken, Japan
Hirosaki University Hospital
Hirosaki-shi, Aomori, Japan
Chiba University Hospital
Chiba, Chiba, Japan
National Hospital Organization Shikoku Cancer Center
Matsuyama, Ehime, Japan
Fukui Prefectural Hospital
Fukui-shi, Fukui, Japan
Kyushu University Hospital
Fukuoka, Fukuoka, Japan
Fukushima Medical University Hospital
Fukushima, Fukushima, Japan
Gifu University Hospital
Gifu, Gifu, Japan
Ogaki Municipal Hospital
Ogaki-shi, Gifu, Japan
Gunma University Hospital
Maebashi, Gunma, Japan
Gunma Prefectural Cancer Center
Ota-shi, Gunma, Japan
Hiroshima City Hiroshima Citizens Hospital
Hiroshima, Hiroshima, Japan
Hiroshima University Hospital
Hiroshima, Hiroshima, Japan
Ibaraki Prefectural Central Hospital
Kasama-shi, Ibaraki, Japan
Ishikawa Prefectural Central Hospital
Kanazawa, Ishikawa-ken, Japan
Kagawa University Hospital
Kita-gun, Kagawa-ken, Japan
St Marianna University Hospital
Kawasaki-shi, Kanagawa, Japan
Kanagawa Prefectural Hospital Organization Kanagawa Cancer Center
Yokohama, Kanagawa, Japan
Kochi Health Sciences Center
Kochi, Kochi, Japan
Kyoto University Hospital
Kyoto, Kyoto, Japan
Tohoku University Hospital
Sendai, Miyagi, Japan
Okayama University Hospital
Okayama, Okayama-ken, Japan
Osaka General Medical Center
Osaka, Osaka, Japan
Osaka Medical and Pharmaceutical University Hospital
Takatsuki-shi, Osaka, Japan
Shizuoka General Hospital
Shizuoka, Shizuoka, Japan
Shizuoka Cancer Center
Sunto-gun, Shizuoka, Japan
Dokkyo Medical University Hospital
Shimotsuga-gun, Tochigi, Japan
National Cancer Center Hospital
Chuo-ku, Tokyo, Japan
The Cancer Institute Hospital of Japanese Foundation for Cancer Research
Koto-ku, Tokyo, Japan
IMSUT Hospital, The Institute of Medical Science The University of Tokyo
Minato-ku, Tokyo, Japan
Toyama University Hospital
Toyama, Toyama, Japan
National University Hospital
Singapore, Singapore
National Cancer Center
Goyang-si Gyeonggi-do, South Korea
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Seoul National University Hospital
Seoul, South Korea
Severance Hospital Yonsei University Health System
Seoul, South Korea
Asan Medical Center
Seoul, South Korea
Samsung Medical Center
Seoul, South Korea
Korea University Guro Hospital
Seoul, South Korea
Showing 40 of 42 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.